Dextrothyroxine (trade name Choloxin) is a dextrorotary isomer of thyroxine.

[1] It saw research as a cholesterol-lowering drug[2] but was pulled due to cardiac side-effects.

It increases hepatic lipase which in turn improves utilization of triglycerides and decreases levels of lipoprotein(a) in blood serum.

[3] This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.